When.com Web Search

  1. Ads

    related to: eau guidelines prostate cancer 2024 latest news

Search results

  1. Results From The WOW.Com Content Network
  2. European Association of Urology - Wikipedia

    en.wikipedia.org/.../European_Association_of_Urology

    An additional example of EAU collaboration with another organisation for the benefit of urology is the World Health Organization (WHO) Consensus Conference on bladder cancer, which was held in April 2008. The European Association of Urology Nurses (EAUN) aims to contribute to the development of higher standards of urology nursing in Europe.

  3. Active surveillance of prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Active_surveillance_of...

    In a separate study of men from the pre prostate cancer screening era managed with watchful waiting (56% over age 70 years), progression to distant metastasis or prostate cancer death was 13.9% and 12.3%, respectively for Gleason score 6 or below, but considerably higher at 18.2 and 22.7%, 30% and 20%, 44.4% and 55.6% for Gleason 3+4, 4+3, and ...

  4. PSMA scan - Wikipedia

    en.wikipedia.org/wiki/PSMA_scan

    A 2024 overview of reviews published in Seminars of Nuclear Medicine concluded that while evidence gaps remain for some outcomes and most systematic reviews are at high or unclear risk of bias, the evidence base is broadly supportive of 18-F PSMA PET/CT in patients with high-risk prostate cancer or biochemical recurrence [10]

  5. Prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer

    Prostate cancer is a major topic of ongoing research. From 2016 to 2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [122] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost ...

  6. European Urology - Wikipedia

    en.wikipedia.org/wiki/European_Urology

    It is the official journal of the European Association of Urology. The editor-in-chief is James Catto of the University of Sheffield . According to the Journal Citation Reports , the journal has a 2022 impact factor of 23.4.

  7. Management of prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Management_of_prostate_cancer

    Bisphosphonates such as zoledronic acid have been shown to delay skeletal complications such as fractures or the need for radiation therapy in patients with hormone-refractory metastatic prostate cancer. [84] Xofigo is a new alpha-emitting pharmaceutical targeting bone metastasis. Phase II testing shows prolonged patient survival times, reduced ...